- Country: Ukraine
- Summary: Buspiron Tablets of 10 Mg Oseltamivir Tablets/Capsules of 75 Mg Pancreatin, Lipolitical Units: 25000
- UAT Ref No: 115094314
- Deadline: 24 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 159848.37
- Notice Type: Tender
- Document Ref. No.: UA-2025-02-19-009589-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- ProZorro ID: UA-2025-02-19-009589-A expected cost: 159 848,37 UAH with VAT type of procurement: The main item of purchase is products, objects of any kind and purpose, including raw materials, products , equipment, technologies, objects in solid, liquid and gaseous state,
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBuspiron Tablets of 10 Mg Oseltamivir Tablets/Capsules of 75 Mg Pancreatin, Lipolitical Units: 25000 - Ukraine Tender
The MUNICIPAL NON -COMMERCIAL ENTERPRISE KHMELNYTSKY REGIONAL INSTITUTION FOR THE PROVISION OF PSYCHIATRIC ASSISTANCE OF THE KHMELNYTSKY REGIONAL COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Buspiron Tablets of 10 Mg Oseltamivir Tablets/Capsules of 75 Mg Pancreatin, Lipolitical Units: 25000. This tender is published on UkraineTenders under UAT Ref No: 115094314 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-24.
The estimated tender value is UAH 159848.37, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
